Back to the main directory
Company Analysis / Equity
- Morningstar | Despite Strong Near-Term Results for U.K. Unit, Long Term Remains a Significant Concern by Morningstar
- Better Late Than Never: Qualcomm Reaches Settlement With Apple; No Change to $72 FVE for QCOM by Morningstar
- Our Wood Product Valuation Fall Along with Our Tempered Housing Starts Forecast by Morningstar
- Morningstar | The State of U.S. Healthcare Laws Has a Low Impact on Australian Healthcare Stock Valuations by Morningstar
- Cuba Policy Change Impacts 2019 Royal Caribbean's Earnings Growth, but Brand Equity Still Strong by Morningstar
- Morningstar | Shaw's 3Q Results Show the Firm Making Strides in Wireless but Still Facing Wireline Challenges by Morningstar
- Telus' Good 1Q Financial Results Slightly Marred by Weak Mobile Phone Net Adds; Maintaining $50 FVE by Morningstar
- Tenaris Remains The Global OCTG Leader by Morningstar
- Lowering FVE Due to Slower Revenue Recovery in Spain and Italy and Higher Spectrum Costs by Morningstar
- Morningstar | Xerox in Paper Jam, but Significant Cost-Cutting Expected by Morningstar
- Stronger Chinese Steel Production Benefits Coking Coal Near-Term, Shares Close to Fairly Valued by Morningstar
- BCE Remains Our Favorite Canadian Telco After Strong Quarter, but It's Approaching Our CAD 63 FVE by Morningstar
- Morningstar | Shaw's 3Q Results Show the Firm Making Strides in Wireless but Still Facing Wireline Challenges by Morningstar
- Morningstar | Further Iron Ore Disruptions Boost Sentiment and Prices, but Those Drivers are Unlikely to Persist by Morningstar
- Morningstar | The State of U.S. Healthcare Laws Has a Low Impact on Australian Healthcare Stock Valuations by Morningstar
- Morningstar | The State of U.S. Healthcare Laws Has a Low Impact on Australian Healthcare Stock Valuations by Morningstar
- Morningstar | Raise Ramsay’s FVE to AUD 70 on Better Margin and Free Cash Flow Outlook. See Updated Analyst Note from 10 May 2019 by Morningstar
- Morningstar | The State of U.S. Healthcare Laws Has a Low Impact on Australian Healthcare Stock Valuations by Morningstar
- Morningstar | The State of U.S. Healthcare Laws Has a Low Impact on Australian Healthcare Stock Valuations by Morningstar
- Morningstar | Further Iron Ore Disruptions Boost Sentiment and Prices, but Those Drivers are Unlikely to Persist by Morningstar
- Morningstar | Moutai’s 4Q 2018 Results Were Upbeat; Raising Our FVE to CNY 830 from Sustainable Profit Growth. See Updated Analyst Note from 29 Mar 2019 by Morningstar
- China Vanke Full-Year Results a Miss on Lower Top Line, but Strong Margin Provides Mitigation by Morningstar
- Enel's Solid Earnings and Dividend Growth Should Drive a Reduction in the Discount to the Sector by Morningstar
- Strong Start for Fresenius Medical Care Bodes Well for Dialysis Providers by Morningstar
- CKI’s Management Is Cautious on Regulatory Resets, Results in Line, FVE Unchanged by Morningstar